Search Tag: Canadian Health Authority
2023 13 Dec
At the end of November 2023, AOP Orphan Pharmaceuticals GmbH ( AOP Health ), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada) for its ultra-short-acting, cardioselective β1-blocker Landiolol. The drug is used in intensive care to treat atrial fibrillation and atrial flutter...Read more